Correspondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort'

Ann Rheum Dis. 2022 Nov;81(11):e218. doi: 10.1136/annrheumdis-2020-218797. Epub 2020 Sep 21.
No abstract available

Keywords: antirheumatic agents; autoimmune diseases; inflammation.

Publication types

  • Letter
  • Multicenter Study
  • Comment

MeSH terms

  • COVID-19* / complications
  • Child
  • Humans
  • Kava*
  • Mucocutaneous Lymph Node Syndrome* / diagnosis
  • SARS-CoV-2
  • Systemic Inflammatory Response Syndrome

Supplementary concepts

  • pediatric multisystem inflammatory disease, COVID-19 related